Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Biocompatibility of glycerol monooleate nanoparticles as tested on inner ear cells
University of Padua, Italy.
Ear Science Institute Australia, Australia; University of Western Australia, Australia.
RISE - Research Institutes of Sweden, Biovetenskap och material, Yta, process och formulering.ORCID-id: 0000-0003-4742-1702
RISE - Research Institutes of Sweden, Biovetenskap och material, Yta, process och formulering.ORCID-id: 0000-0001-8971-3397
Visa övriga samt affilieringar
2019 (Engelska)Ingår i: International Journal of Pharmaceutics, ISSN 0378-5173, E-ISSN 1873-3476, Vol. 572, artikel-id 118788Artikel i tidskrift (Refereegranskat) Epub ahead of print
Abstract [en]

Sensorineural hearing loss due to aging, noise exposure, trauma or drug ototoxicity is irreversible because cochlear hair cells and neurons cannot regenerate. Recently, therapeutic strategies involving nanoparticles have been developed as innovative drug delivery systems. Thermodynamically stable liquid crystalline nanoparticles based on the polar lipid glycerol monooleate (GMO NP, cubosomes), nontoxic and able to encapsulate both hydrophilic and hydrophobic compounds, were produced and tested for biocompatibility in an immortalized Organ of Corti derived cell line (OC-k3), through cell viability and cytomorphological assays, and Western blot expression profiles of apoptotic markers. Overall, the GMO NP were biocompatible in OC-k3 at the doses and time tested, supporting previous data obtained in a neuronal cell line (PC12). The results encourage further tests on GMO NP-mediated drug release with improved target specificity and could be useful to develop innovative therapies against sensorineural hearing loss.

Ort, förlag, år, upplaga, sidor
Elsevier B.V. , 2019. Vol. 572, artikel-id 118788
Nyckelord [en]
Apoptosis, Cell cycle, Cubosome, OC-k3 cells, Toxicity
Nationell ämneskategori
Naturvetenskap
Identifikatorer
URN: urn:nbn:se:ri:diva-40932DOI: 10.1016/j.ijpharm.2019.118788Scopus ID: 2-s2.0-85075399346OAI: oai:DiVA.org:ri-40932DiVA, id: diva2:1376728
Anmärkning

Funding details: Prat-CPDA110048; Funding details: Ministero dell’Istruzione, dell’Università e della Ricerca, MIUR, PRIN-2010S58B38_004; Funding text 1: This work was supported by the Italian Ministry of Education, University and Research (MIUR) , Italy [grant n. PRIN-2010S58B38_004 ] and the University of Padua (grant n. Prat-CPDA110048 ).

Tillgänglig från: 2019-12-10 Skapad: 2019-12-10 Senast uppdaterad: 2020-01-17Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextScopus

Personposter BETA

Boge, LukasEriksson, Mimmi

Sök vidare i DiVA

Av författaren/redaktören
Boge, LukasEriksson, Mimmi
Av organisationen
Yta, process och formulering
I samma tidskrift
International Journal of Pharmaceutics
Naturvetenskap

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetricpoäng

doi
urn-nbn
Totalt: 10 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
v. 2.35.10